Kiora Pharmaceuticals (FRA:7EY) Cyclically Adjusted Book per Share: €87.88 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7EY Kiora Pharmaceuticals Inc FRA:7EY
34 GF Score
Price €0.42
! 3 Warning Signs
View Full Analysis

What is Kiora Pharmaceuticals Cyclically Adjusted Book per Share?

Kiora Pharmaceuticals FRA:7EY 34 Cyclically Adjusted Book per Share is €87.88 as of Jun. 2026. GuruFocus rates FRA:7EY with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Kiora Pharmaceuticals's adjusted book value per share for the three months ended in Jun. 2026 was €3.305. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €87.88 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Kiora Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -56.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-14), Kiora Pharmaceuticals's current stock price is €0.4208. Kiora Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €87.88. Kiora Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.00.


Kiora Pharmaceuticals  (FRA:7EY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kiora Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.4208/87.88
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Kiora Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Kiora Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Kiora Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kiora Pharmaceuticals Cyclically Adjusted Book per Share Chart

Kiora Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -4,952.43 -4,170.29 169.20 161.25

Kiora Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.04 146.14 161.25 142.54 87.88

FRA:7EY vs PBM, AEON, XCUR: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Kiora Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kiora Pharmaceuticals Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kiora Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kiora Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


FRA:7EY
34GF Score
Kiora Pharmaceuticals Inc FRA:7EY
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kiora Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kiora Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.305/333.9520*333.9520
=3.305

Current CPI (Jun. 2026) = 333.9520.

Kiora Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201609 1,445.500 241.428 1,999.468
201612 -156.000 241.432 -215.781
201703 -536.000 243.801 -734.198
201706 1,355.333 244.955 1,847.752
201709 190.000 246.819 257.075
201712 -542.667 246.524 -735.120
201803 1,426.667 249.554 1,909.159
201806 1,449.625 251.989 1,921.136
201809 1,189.125 252.439 1,573.096
201812 981.875 251.233 1,305.159
201903 1,110.625 254.202 1,459.058
201906 937.250 256.143 1,221.960
201909 591.500 256.759 769.331
201912 541.818 256.974 704.123
202003 648.692 258.115 839.285
202006 532.692 257.797 690.053
202009 389.308 260.280 499.501
202012 533.200 260.474 683.612
202103 532.750 264.877 671.681
202106 433.850 271.696 533.262
202109 421.314 274.310 512.918
202112 368.629 278.802 441.548
202203 292.057 287.504 339.241
202206 230.250 296.311 259.499
202209 88.550 296.808 99.632
202212 53.845 296.797 60.586
202303 44.535 301.836 49.274
202306 16.396 305.109 17.946
202309 8.891 307.789 9.647
202312 6.546 306.746 7.127
202403 11.009 312.332 11.771
202406 10.351 314.175 11.003
202409 9.016 315.301 9.549
202412 8.198 315.605 8.675
202503 7.305 319.799 7.628
202506 5.588 322.561 5.785
202509 5.562 324.800 5.719
202512 3.661 324.054 3.773
202603 3.019 330.213 3.053
202606 3.305 333.952 3.305

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €87.88 mean?
Kiora Pharmaceuticals (FRA:7EY) has a Cyclically Adjusted Book per Share of €87.88 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Kiora Pharmaceuticals and its competitors.
Is Kiora Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Kiora Pharmaceuticals' current Cyclically Adjusted Book per Share is €87.88. Overall, Kiora Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Kiora Pharmaceuticals' Cyclically Adjusted Book per Share compare to PBM and AEON?
Kiora Pharmaceuticals' Cyclically Adjusted Book per Share of €87.88 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Kiora Pharmaceuticals and its competitors. Kiora Pharmaceuticals's current Cyclically Adjusted Book per Share is €87.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kiora Pharmaceuticals stock overvalued right now?
Kiora Pharmaceuticals (FRA:7EY) has a current Cyclically Adjusted Book per Share of €87.88. The current Cyclically Adjusted Book per Share is €87.88. Kiora Pharmaceuticals' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Kiora Pharmaceuticals (FRA:7EY), the current Cyclically Adjusted Book per Share is €87.88 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kiora Pharmaceuticals Business Description

Other Exchanges KPRX:USA
Address 169 Saxony Road, Suite 212, Encinitas, CA, USA, 92024
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
34GF Score

Get the complete analysis for FRA:7EY

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.42
Price